Pemetrexed Disodium Patent Expiration
Pemetrexed Disodium was first introduced by Eli Lilly And Co
Pemetrexed Disodium Patents
Given below is the list of patents protecting Pemetrexed Disodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Alimta | US5344932 | N-(pyrrolo(2,3-d)pyrimidin-3-ylacyl)-glutamic acid derivatives |
Jul 24, 2016
(Expired) | Lilly |
| Alimta |
US5344932 (Pediatric) | N-(pyrrolo(2,3-d)pyrimidin-3-ylacyl)-glutamic acid derivatives |
Jan 24, 2017
(Expired) | Lilly |
| Alimta | US7772209 | Antifolate combination therapies |
Nov 24, 2021
(Expired) | Lilly |
| Alimta |
US7772209 (Pediatric) | Antifolate combination therapies |
May 24, 2022
(Expired) | Lilly |
| Pemetrexed | US11147817 | Pharmaceutical composition of pemetrexed | Mar 26, 2035 | Shilpa |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Pemetrexed Disodium Generics
Several generic applications have been filed for Pemetrexed Disodium. The first generic version for Pemetrexed Disodium was by Fresenius Kabi Usa Llc and was approved on May 25, 2022. And the latest generic version is by Hetero Labs Ltd Unit Vi and was approved on Jun 14, 2024.
Given below is the list of companies who have filed for Pemetrexed Disodium generic.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 3 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 1GM BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
2. NANG KUANG PHARM CO
Nang Kuang Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Nang Kuang Pharm Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
3. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 1GM BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
4. BIOCON PHARMA
Biocon Pharma Ltd has filed for 1 generic for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Biocon Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 1GM BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | May 25, 2022 |
5. QILU PHARM HAINAN
Qilu Pharmaceutical Hainan Co Ltd has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Qilu Pharm Hainan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
6. AMNEAL
Amneal Eu Ltd has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 500MG BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | Aug 4, 2022 |
| EQ 100MG BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | May 8, 2023 |
7. RELIANCE LIFE
Reliance Life Sciences Pvt Ltd has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Reliance Life.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
8. HOSPIRA
Hospira Inc has filed for 3 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | May 25, 2022 |
| EQ 500MG BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | May 25, 2022 |
| EQ 1GM BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | May 25, 2022 |
9. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 1 generic for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 500MG BASE/VIAL | powder | Discontinued | INTRAVENOUS | N/A | Mar 10, 2023 |
10. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 1 generic for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | Dec 11, 2023 |
11. BAXTER HLTHCARE CORP
Baxter Healthcare Corp has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | Aug 18, 2022 |
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | Aug 18, 2022 |
12. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 4 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | Dec 13, 2022 |
| EQ 750MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | Dec 13, 2022 |
| EQ 1GM BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | Dec 13, 2022 |
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | Dec 13, 2022 |
13. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 1GM BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
14. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 3 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 1GM BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
15. HETERO LABS LTD VI
Hetero Labs Ltd Unit Vi has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Vi.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | Jun 14, 2024 |
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | Jun 14, 2024 |
16. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 4 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 750MG BASE/VIAL
(reference standard) | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 1GM BASE/VIAL
(reference standard) | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
17. APOTEX
Apotex Inc has filed for 4 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 1GM BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 750MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
18. JIANGSU HANSOH PHARM
Jiangsu Hansoh Pharmaceutical Group Co Ltd has filed for 2 different strengths of generic version for Pemetrexed Disodium. Given below are the details of the strengths of this generic introduced by Jiangsu Hansoh Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 100MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |
| EQ 500MG BASE/VIAL | powder | Prescription | INTRAVENOUS | AP | May 25, 2022 |